110
Participants
Start Date
August 5, 2024
Primary Completion Date
June 30, 2027
Study Completion Date
May 31, 2028
BNT327 Dose Level 1 (DL1)
Intravenous (IV) infusion
BNT327 Dose Level 2 (DL2)
IV infusion
Etoposide
IV infusion
Carboplatin
IV infusion
Paclitaxel
IV infusion
Topotecan
IV infusion or oral capsules
Royal North Shore Hospital, St Leonards
Westmead Hospital, Westmead
St. Vincent's Hospital, Fitzroy
Peninsula Oncology Centre, Frankston
Adana City Training and Research Hospital, Adana
Lyell McEwin Hospital, Adelaide
National Cancer Center, Goyang-si
Clinical Research Alliance Inc, Westbury
Ajou University Hospital, Suwon
Gachon University Gil Medical Center, Incheon
FirstHealth Outpatient Cancer Center, Pinehurst
Chungbuk National University Hospital, Cheongju-si
Tallahassee Memorial Physician Partners - Cancer & Hematology Specialists, Tallahassee
Koc Universitesi Hastanesi (Koc University Hospital), Istanbul
Bezmialem Vakif Universitesi Tip Fakultesi Hastanesi, Istanbul
Acibadem Adana Hastanesi, Istanbul
Clermont Oncology Center, Clermont
Yeditepe University Kosuyolu Hospital, Istanbul
Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul
Hematology Oncology Associates of Treasure Coast, Port Saint Lucie
Medical Point Izmir Hospital, Izmir
Gaziantep Sanko University Medical Faculty, Gaziantep
University of Tennessee Medical Center, Knoxville
University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington
Kocaeli Universitesi Tip Fakultesi, Kocaeli
Yeungnam University Medical Center, Daegu
The Christ Hospital Cancer Center, Cincinnati
Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
Gyeongsang National University Hospital (GNUH), Jinju
SSM Health Cancer Care, Madison
Sakarya University - Faculty of Medicine, Sakarya
Allina Health, Minneapolis
Namik Kemal University Hospital, Tekirdağ
Carle Foundation Hospital d/b/a Carle Cancer Center, Urbana
SSM Health Cancer Care - St. Clare, Fenton
Nebraska Hematology-Oncology (NHO) - Lincoln, Lincoln
Millenium Research & Clinical Development, Houston
Valkyrie Clinical Trials, Los Angeles
Alaska Oncology and Hematology, LLC, Anchorage
Haywood Infusion Center, Clyde
Korea University Anam Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Baskent University Hospital Adana Dr Turgut Noyan Research Center, Adana
Medical Park Seyhan Hospital, Adana
Gulhane Egitim ve Arastirma Hastanesi, Ankara
Ankara Etlik Sehir Hastanesi, Ankara
Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara
Hacettepe University Medical Faculty Oncology Hospital, Ankara
Memorial Ankara Hospital, Ankara
Liv Hospital, Ankara
Ankara City Hospital, Ankara
Gazi University Medical Faculty, Yenimahalle
Queen Elizabeth Hospital Birmingham - University Hospitals Birmingham NHS Foundation Trust, Birmingham
Velindre Hospital - Velindre NHS Trust, Cardiff
Ninewells Hospital and Medical School - Tayside Health Board, Dundee
Royal Devon and Exeter Hospital, Wonford - Royal Devon And Exeter NHS Foundation Trust, Exeter
Huddersfield Royal Infirmary - Calderdale and Huddersfield NHS Foundation Trust, Huddersfield
St James's University Hospital - Leeds Teaching Hospitals NHS Trust, Leeds
Sarah Cannon Research Institute, London
Northern Centre for Cancer Care,The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Nottingham University Hospitals NHS Trust, Nottingham
Royal Preston Hospital - Lancashire Teaching Hospitals NHS Foundation Trust, Preston
Royal Stoke University Hospital - University Hospitals of North Midlands NHS Trust, Stoke-on-Trent
Lead Sponsor
BioNTech SE
INDUSTRY